6/27/2025

Medtronic plc (NYSE:MDT) is one of the Best Wide Moat Dividend Stocks to Invest in. The company remains a major player in the medical technology space as it focuses on medical devices. Its broad product lineup targets a variety of chronic conditions, including heart disease, diabetes, chronic pain, and acute care needs. With strengths across […]

Source: Yahoo

6/26/2025

JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.

Source: Yahoo

6/26/2025

As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?

Source: Yahoo

6/26/2025

Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.

Source: Yahoo

6/25/2025

Medtronic, Inc. (NYSE:MDT) ranks among the top stocks for an early retirement portfolio. On June 18, RBC Capital reiterated a $101 price target and an Outperform rating on Medtronic, Inc. (NYSE:MDT), emphasizing the company’s renal denervation system as an undervalued market opportunity. The firm assessed the potential of Medtronic’s Symplicity Spyral renal denervation system, which […]

Source: Yahoo

6/25/2025

Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” in 4 years.” Shares of companies in the continuous glucose monitoring space moved higher intraday, including Tandem Diabetes (TNDM), DexCom (DXCM), Insulet (PODD), Abbott (ABT) and Medtronic (MDT). Published first on TheFly – the ultimate source for real-time, m

Source: Yahoo

6/25/2025

The Food and Drug Administration published an early alert for the recall on Tuesday. No deaths have been associated with the problem.

Source: Yahoo

6/25/2025

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

Source: Yahoo

6/25/2025

The U.S. insulin pen market is set to grow from USD 4.2 billion in 2024 to USD 8.1 billion by 2033 at a 6.9% CAGR. Key growth drivers include advanced technology, increased awareness, and favorable reimbursement policies. Major players: Eli Lilly, Sanofi, Glooko, Medtronic, Novo Nordisk, Owen Mumford. U.S. Insulin Pens Market U.S. Insulin Pens Market Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "United States Insulin Pens Market Size, Insights, Competitive Landscape, and Forecast, 2025 - 2033"

Source: Yahoo

6/24/2025

The board of Medtronic plc ( NYSE:MDT ) has announced that it will be paying its dividend of $0.71 on the 11th of July...

Source: Yahoo

6/24/2025

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.

Source: Yahoo

6/24/2025

Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.

Source: SeekingAlpha

6/24/2025

Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.

Source: SeekingAlpha

6/23/2025

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board.

Source: Yahoo

6/22/2025

Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%.

Source: Yahoo

6/21/2025

Source: SeekingAlpha

6/20/2025

Source: SeekingAlpha

6/20/2025

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Source: Yahoo

6/20/2025

DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook.

Source: Yahoo

6/20/2025

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.

Source: Yahoo